タキザワ マキコ
TAKIZAWA Makiko
滝沢 牧子 所属 埼玉医科大学 医学部 総合医療センター 医療安全管理学 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Clinical management and outcomes of completely resected stage I follicular lymphoma. |
掲載誌名 | 正式名:Journal of clinical and experimental hematopathology : JCEH |
掲載区分 | 国内 |
巻・号・頁 | 58(1),10-16頁 |
著者・共著者 | Akihiko Yokohama,Yoko Hashimoto,Makiko Takizawa,Hiroaki Shimizu,Yuri Miyazawa,Akio Saitoh,Kohtaro Toyama,Takuma Ishizaki,Takeki Mitsui,Takayuki Saitoh,Kayoko Murayama,Morio Matsumoto,Morio Sawamura,Hirokazu Murakami,Junko Hirato,Masaru Kojima,Yoshihisa Nojima,Hiroshi Handa,Norifumi Tsukamoto |
発行年月 | 2018/03/16 |
概要 | Recent studies have revealed the clinical and biological features of stage I follicular lymphoma (FL), but information about patients with stage I FL who underwent total resection after tissue biopsy is limited. Among 305 FL patients diagnosed between 2001 and 2013, clinical stage I disease was observed in 36 patients. Of these, 18 patients underwent total resection after diagnostic tissue biopsy. We used 18F-fluorodeoxyglucose positron emission CT for staging assessment in 13 of 18 patients (72.2%). The median age was 56.5 years. Six patients (33.3%) were male. The soluble interleukin-2 receptor alpha concentration was significantly lower than in patients with residual disease. Among these 18 patients, 7 patients (38.9%) were treated with a "watch-and-wait" (WW) policy, 7 (38.9%) were treated with involved-field irradiation, and 4 (22.2%) received systemic chemotherapy. Patients with resected disease were treated with significantly different strategies from those with residual disease (p = 0.0026). Five patients experienced relapse during follow-up (median follow-up: 48.2 months). All relapses were distant from the primary site, irrespective of treatment strategy. Among all stage I patients, disease resection was not a significant factor for survival (p = 0.9294). Collectively, the choice of treatment strategy was significantly influenced by patient status. Resection status was not significantly associated with survival after several treatment strategies. |
DOI | 10.3960/jslrt.17031 |
PMID | 29415976 |